Head-to-head · Value Score
Vitara RX vs EdgeRx
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, EdgeRx a 82. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameEdgeRx
#53 · Grade B+ · Good Value
Est. first month
$229/mo
Save ~83% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 82 — an est. $99/mo first month, with no teaser step-up baked in. EdgeRx isn't out of it: Men who want a straightforward, disclosed weekly-injectable price on either molecule and value knowing the pharmacy filling the script by name.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | EdgeRx |
|---|---|---|
| Value Score | 91 (A) | 82 (B+) |
| Est. first month | $99/mo | $229/mo |
| Save vs brand-name | ~93% | ~83% |
| Semaglutide | $99/mo | $229/mo injectable |
| Tirzepatide | $149/mo | $299/mo injectable |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | 49 states | 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
EdgeRx
A men's-only protocol shop with flat, disclosed GLP-1 pricing, a named Chief Medical Advisor, and a named 503A compounding pharmacy — rare transparency for this tier of the board.
Why it's a deal
- Both molecules disclosed up front — semaglutide $229/mo, tirzepatide $299/mo, both once-weekly injectable with free shipping and no separate physician fee
- Named compounding pharmacy — Strive Pharmacy, 503A, operating since 2018 — most peers name none
- Named Chief Medical Advisor, Dr. John Starke, MD (ABEM board-certified)
- LegitScript certified
The fine print
- Men-only — not built for, or marketed to, women or other readers
- The named Chief Medical Advisor does not personally prescribe; the actual prescribing pool is unnamed licensed physicians
- Third-party lab testing is claimed but no specific lab is named
- Excludes Arkansas, Indiana, Minnesota, and South Carolina
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to EdgeRx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.